Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 21, 2022; 28(31): 4299-4309
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4299
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4299
Ref. | Cancer | Cases | Groups | Conclusion |
RT in EAC and EGJA | ||||
Zhou et al[33], 2021 | EGJA (Siewert II) | 4160 | nRT vs RT | nRT improves prognosis in patients with more advanced tumors |
Klevebro et al[35], 2016 | Esophageal or EGJ cancer | 181 | nCRT vs nCT | nCRT group had higher complete response rate, R0 resection rate, and lower lymph-node metastases, without significantly affecting survival |
Ristau et al[36], 2021 | EC | 101 | RT vs CT | RT could partially compensate for CT |
CT in EAC and EGJA | ||||
Mokdad et al[37], 2018 | Lower EAC or EGJA | 10086 | CT vs observation | Most patients benefited from adjuvant CT for OS |
Papaxoinis et al[38], 2019 | Lower EAC or EGJA | 312 | nCT vs CT | No significant differences; only patients with postoperative microscopic residual disease benefited from postoperative CT |
Davies et al[39], 2014 | EAC or EGJA | 584 | Downstaging after nCT vs no response | Tumor stage after nCT is more closely associated with prognosis and eligibility for surgery |
Bunting et al[41], 2018 | EAC | 286 | Toxicity of nCT vs no toxicity | Toxicity can lead to adverse consequences, such as failure to complete CT, loss of opportunity for surgical resection, and poor OS |
CRT in EAC and EGJA | ||||
Shapiro et al[44], 2015 | Esophageal or EGJ cancer | 368 | nCT + surgery vs surgery alone | Patients with resectable esophageal or EGJ carcinoma benefited more from nCRT plus surgery than surgery alone |
Zafar et al[46], 2020 | Lower EAC or EGJA | 13783 | nCRT vs nCT | nCRT group was more likely to achieve pCR; OS was not statistically different |
Al-Sukhni et al[47], 2016 | EAC or EGJA | 6986 | nCRT vs nCT | nCRT group showed no difference in improving survival in resectable tumor |
Samson et al[48], 2016 | EC | 7338 | nCRT vs nCT | nCRT lead to more downstaging of tumor, but it is not an individual prognostic factor |
Li et al[50], 2021 | EGJA (Siewert II/III) | 170 | nCRT vs nCT | nCRT provided better survival and improved R0 removal and pCR rates more than nCT in patients with locally advanced EJGA |
Tian et al[51], 2020 | Gastric or EGJ adenocarcinoma | 1048 | Perioperative CRT vs perioperative CT | Perioperative CRT was associated with a higher pCR rate but increase the risk of mortality |
Noordman et al[52], 2018 | Esophageal or EGJ cancer | 368 | nCRT + surgery vs surgery alone | Physical function and frailty remained relatively low in nCRT group, but no adverse effects on long-term HRQoL were observed |
Noordman et al[53], 2019 | Esophageal or EGJ cancer | 96 | nCRT | HRQoL reduced in short-term, but would return to baseline |
Noordman et al[54], 2018 | Esophageal or EGJ cancer | 363 | nCRT + surgery vs surgery alone | nCRT had no significant effect on postoperative HRQoL |
Nilsson et al[55], 2020 | Esophageal or EGJ cancer | 249 | Standard TTS vs prolonged TTS | Time to surgery (TTS) after nCRT had no significant effect on short-term prognosis |
- Citation: Zheng YH, Zhao EH. Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction. World J Gastroenterol 2022; 28(31): 4299-4309
- URL: https://www.wjgnet.com/1007-9327/full/v28/i31/4299.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i31.4299